Rentschler Biopharma Capabilities Update May 2026: Large Molecule

Rentschler Biopharma is a global leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals, as well as related consulting activities, project management and regulatory support.

Rentschler Biopharma's high quality is reflected in its long-standing experience and its role as a trusted solution partner for clients. A high-level quality management system, a well-established operational excellence philosophy and advanced technologies ensure product quality and productivity at each development and manufacturing step.

Rentschler Biopharma is a family-owned company with about 1,400 employees, headquartered in Laupheim, Germany, with operations in Milford, MA, USA. In 2024, the company joined the United Nations Global Compact, underscoring Rentschler Biopharma’s commitment to sustainability.